نتائج البحث - "Glucagon-Like Peptide-1 Receptor / agonists"

1

دورية أكاديمية

Is the GLP-1 receptor agonist, semaglutide, a good option for weight loss in persons with HIV?

المؤلفون: Lee, Daniel, Capeau, Jacqueline

المصدر: AIDS. 38(4)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Health Sciences, Humans, Glucagon-Like Peptide-1 Receptor Agonists, HIV Infections, Glucagon-Like Peptides, Weight Loss, Biological Sciences, Medical and Health Sciences, Psychology and Cognitive Sciences, Virology, Biomedical and clinical sciences, Health sciences

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/6rc7x18bTest

View record in eScholarship

2

دورية أكاديمية

Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy

المؤلفون: Cesta, Carolyn E., Rotem, Ran, Bateman, Brian T., Chodick, Gabriel, Cohen, Jacqueline M., Furu, Kari, Gissler, Mika, Huybrechts, Krista F., Kjerpeseth, Lars J., Leinonen, Maarit K., Pazzagli, Laura, Zoega, Helga, Seely, Ellen W., Patorno, Elisabetta, Hernández-Díaz, Sonia

المساهمون: Faculty of Medicine

مصطلحات موضوعية: Cohort Studies, Diabetes Mellitus, Type 2/drug therapy, Dipeptidyl-Peptidase IV Inhibitors/therapeutic use, Female, Glucagon-Like Peptide-1 Receptor Agonists, Glucagon-Like Peptide-1 Receptor/agonists, Humans, Hypoglycemic Agents/adverse effects, Insulin/adverse effects, Pregnancy, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sulfonylurea Compounds/adverse effects, Internal Medicine

وصف الملف: 144-152

العلاقة: JAMA Internal Medicine; 184(2); http://www.scopus.com/inward/record.url?scp=85181034956&partnerID=8YFLogxKTest; Cesta , C E , Rotem , R , Bateman , B T , Chodick , G , Cohen , J M , Furu , K , Gissler , M , Huybrechts , K F , Kjerpeseth , L J , Leinonen , M K , Pazzagli , L , Zoega , H , Seely , E W , Patorno , E & Hernández-Díaz , S 2024 , ' Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy ' , JAMA Internal Medicine , vol. 184 , no. 2 , pp. 144-152 . https://doi.org/10.1001/jamainternmed.2023.6663Test; 215155202; 198ef4fd-ee4e-4302-b551-12e929142bad; 85181034956; https://hdl.handle.net/20.500.11815/4806Test

الإتاحة: https://doi.org/20.500.11815/4806Test
https://doi.org/10.1001/jamainternmed.2023.6663Test
https://hdl.handle.net/20.500.11815/4806Test

View record in BASE

3

دورية أكاديمية

Vignette thérapeutique de l’étudiant. Patient avec un diabète de type 2, une coronaropathie et une insuffisance cardiaque.
Patient with type 2 diabetes and coronary heart disease developing heart failure.

المؤلفون: Scheen, André, Paquot, Nicolas, Lancellotti, Patrizio

المصدر: Revue Médicale de Liège, 79 (4), 260-264 (2024-04)

العلاقة: urn:issn:0370-629X; urn:issn:2566-1566

الوصول الحر: https://orbi.uliege.be/handle/2268/316759Test

View record in ORBi

4

دورية أكاديمية

Geographic variation in sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia

المؤلفون: de Oliveira Costa, J, Lin, J, Milder, TY, Greenfield, JR, Day, RO, Stocker, SL, Neuen, BL, Havard, A, Pearson, SA, Falster, MO

المصدر: urn:ISSN:1462-8902 ; urn:ISSN:1463-1326 ; Diabetes, Obesity and Metabolism, 26, 7, 2787-2795

وصف الملف: application/pdf

العلاقة: http://hdl.handle.net/1959.4/102333Test; https://unsworks.unsw.edu.au/bitstreams/4eed81ac-aad7-4fff-a5db-c74f19484d11/downloadTest; https://doi.org/10.1111/dom.15597Test

الإتاحة: https://doi.org/10.1111/dom.15597Test
http://hdl.handle.net/1959.4/102333Test
https://unsworks.unsw.edu.au/bitstreams/4eed81ac-aad7-4fff-a5db-c74f19484d11/downloadTest

View record in BASE

5

دورية أكاديمية

Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria

المؤلفون: Neuen, BL, Heerspink, HJL, Vart, P, Claggett, BL, Fletcher, RA, Arnott, C, de Oliveira Costa, J, Falster, MO, Pearson, SA, Mahaffey, KW, Neal, B, Agarwal, R, Bakris, G, Perkovic, V, Solomon, SD, Vaduganathan, M

المصدر: urn:ISSN:0009-7322 ; urn:ISSN:1524-4539 ; Circulation, 149, 6, 450-462

مصطلحات موضوعية: Heart Disease, Cardiovascular, Diabetes, Clinical Research, Kidney Disease, 5 Development of treatments and therapeutic interventions, 6.1 Pharmaceuticals, 6 Evaluation of treatments and therapeutic interventions, 5.1 Pharmaceuticals, Metabolic and endocrine, Renal and urogenital, 3 Good Health and Well Being, Humans, Middle Aged, Diabetes Mellitus, Type 2, Sodium-Glucose Transporter 2 Inhibitors, Diabetic Nephropathies, Canagliflozin, Glucagon-Like Peptide-1 Receptor Agonists, Albuminuria, Cardiovascular Diseases, Kidney, Renal Insufficiency, Chronic, Glucagon-Like Peptide 1, heart failure, mortality, treatment outcome, anzsrc-for: 1102 Cardiorespiratory Medicine and Haematology

وصف الملف: application/pdf

العلاقة: http://hdl.handle.net/1959.4/unsworks_84901Test; https://unsworks.unsw.edu.au/bitstreams/f7a94e6a-e786-4975-b116-8384bfa0e43c/downloadTest; https://doi.org/10.1161/CIRCULATIONAHA.123.067584Test

الإتاحة: https://doi.org/10.1161/CIRCULATIONAHA.123.067584Test
http://hdl.handle.net/1959.4/unsworks_84901Test
https://unsworks.unsw.edu.au/bitstreams/f7a94e6a-e786-4975-b116-8384bfa0e43c/downloadTest

View record in BASE

6

دورية أكاديمية

Changes in the use of glucose-lowering drugs: A Danish nationwide study

المؤلفون: Pottegard, Anton, Andersen, Jacob H., Sondergaard, Jens, Thomsen, Reimar W., Vilsboll, Tina

المصدر: Pottegard , A , Andersen , J H , Sondergaard , J , Thomsen , R W & Vilsboll , T 2023 , ' Changes in the use of glucose-lowering drugs: A Danish nationwide study ' , Diabetes, Obesity and Metabolism , vol. 25 , no. 4 , pp. 1002-1010 . https://doi.org/10.1111/dom.14947Test